Catechins containing a galloyl moiety as potential anti-HIV-1 compounds

被引:22
|
作者
Zhao, Yali [1 ]
Jiang, Fan [1 ]
Liu, Ping [1 ]
Chen, Wei [1 ]
Yi, Kejia [2 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China
[2] Beijing Sci Technol & Management Coll, Beijing, Peoples R China
关键词
GREEN TEA CATECHINS; SEMEN-MEDIATED ENHANCEMENT; EPIGALLOCATECHIN-GALLATE; HIV-1; PROTEASE; REVERSE-TRANSCRIPTASE; CD4; POLYPHENOL; BINDING; REPLICATION; METABOLISM;
D O I
10.1016/j.drudis.2012.02.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Catechins containing galloyl moieties are important natural antioxidant compounds. In this paper, we review the multiple mechanisms whereby catechins containing a galloyl moiety can target key proteins to inhibit sexual transmission of HIV-1, as well as HIV-1 fusion, HIV-1 reverse transcriptase, HIV-1 integrase and HIV-1 protease. Furthermore, catechins with a galloyl moiety can mediate host cell factors such as nitric oxide synthase, nuclear factor-kappa B and casein kinase II to inhibit HIV-1 infection. The most significant inhibitory effect is blocking gp120 binding to isolated human CD4(+) T cells. The multiple mechanisms underlying the anti-HIV activity of galloyl-containing catechins predict that these catechins could be used as alternative therapies in the treatment of HIV infection.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 50 条
  • [21] Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis
    Wang, Rui-Rui
    Gu, Qiong
    Wang, Yun-Hua
    Zhang, Xue-Mei
    Yang, Liu-Meng
    Zhou, Jun
    Chen, Ji-Jun
    Zheng, Yong-Tang
    JOURNAL OF ETHNOPHARMACOLOGY, 2008, 117 (02) : 249 - 256
  • [22] Anti-HIV-1 activity of benzothiadiazine dioxide
    Martinez, A
    Gil, C
    Castro, A
    Perez, C
    Witvrouw, M
    Pannecouque, C
    Balzarini, J
    De Clercq, E
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2001, 12 (06) : 347 - 351
  • [23] Anti-HIV-1 activity of herbs in Labiatae
    Yamasaki, K
    Nakano, M
    Kawahata, T
    Mori, H
    Otake, T
    Ueba, N
    Oishi, I
    Inami, R
    Yamane, M
    Nakamura, M
    Murata, H
    Nakanishi, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (08) : 829 - 833
  • [24] Docking of anti-HIV-1 oxoquinoline-acylhydrazone derivatives as potential HSV-1 DNA polymerase inhibitors
    Yoneda, Julliane Diniz
    Albuquerque, Magaly Girao
    Leal, Katia Zaccur
    Santos, Fernanda da Costa
    Batalha, Pedro Netto
    Brozeguini, Leonardo
    Seidl, Peter R.
    de Alencastro, Ricardo Bicca
    Cunha, Anna Claudia
    de Souza, Maria Cecilia B. V.
    Ferreira, Vitor F.
    Giongo, Viveca A.
    Cirne-Santos, Claudio
    Paixao, Izabel C. P.
    JOURNAL OF MOLECULAR STRUCTURE, 2014, 1074 : 263 - 270
  • [25] Application of 3D-QSAR techniques in anti-HIV-1 drug design - An overview
    Debnath, AK
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (24) : 3091 - 3110
  • [26] Human semen contains exosomes with potent anti-HIV-1 activity
    Madison, Marisa N.
    Roller, Richard J.
    Okeoma, Chioma M.
    RETROVIROLOGY, 2014, 11
  • [27] In vitro anti-HIV-1 activity of fucoidan from Sargassum swartzii
    Dinesh, Subramaniam
    Menon, Thangam
    Hanna, Luke E.
    Suresh, V.
    Sathuvan, M.
    Manikannan, M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 82 : 83 - 88
  • [28] Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase
    Ratanabunyong, Siriluk
    Aeksiri, Niran
    Yanaka, Saeko
    Yagi-Utsumi, Maho
    Kato, Koichi
    Choowongkomon, Kiattawee
    Hannongbua, Supa
    CHEMBIOCHEM, 2021, 22 (05) : 915 - 923
  • [29] Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
    Feng, Xiao-Qing
    Liang, Yong-Hong
    Zeng, Zhao-Sen
    Chen, Fen-Er
    Balzarini, Jan
    Pannecouque, Christophe
    De Clercq, Erik
    CHEMMEDCHEM, 2009, 4 (02) : 219 - 224
  • [30] Late-Stage Derivatization of Oleanolic Acid-Based Anti-HIV-1 Compounds
    Takeuchi, Reon
    Fujimoto, Junko
    Taguchi, Yoshinori
    Ide, Ryuji
    Kyan, Ryuji
    Sato, Kohei
    Mase, Nobuyuki
    Yokoyama, Masaru
    Harada, Shigeyoshi
    Narumi, Tetsuo
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (03) : 330 - 335